- 更多网络例句与阿托品相关的网络例句 [注：此内容来源于网络，仅供参考]
-
Methods We analysed 42 patients in different groups, and compared the relationship between the incidence of RMP and the atropine dosage in different groups.
方法对 4 2例不同组别农药中毒病人进行分类分析，比较不同组别中阿托品治疗导致RMP的发生率及阿托品用量间的关系。
-
They were randomly assigned to three arms, 21 were treated with 0.25 % atropine eye drop every night, 20 were treated with 0.5 % atropine eyedrop every night, and 23 were treated with 0.25 % atropine eye drop every night combined with auricular acupressure three times a day for at least 6 months.
以随机方式分配为三组，其中单独点用0.25 %阿托品眼药水组为第一组有21人，单独点用0.5 %阿托品眼药水组为第二组有20人，合并点用0.25 %阿托品眼药水加上耳穴贴压组为第三组有23人。
-
The two treatment groups were both lower than control group; the atropine group was lower than the tropicamide group;(2) the changes of axial length before and after using eyedrop. there was no evident change in the atropine group; the axial length was obvious prolonged in tropicamide group and control group.(3) the phengophobia symptom.
结果：①近视眼患病率：两治疗组的患病率均小于对照组，同时阿托品组的患病率较托品酰胺组更少；②用药前后眼轴的变化：阿托品组没有明显的变化，托品酰胺组和对照组均有显著的延长；③畏光症状：用药初期两治疗组均有不同程度的症状，用药2月后症状基本消失。
-
The two treatment groups were both lower than control group; the atropine group was lower than the tropicamide group;(2) the changes of axial length before and after using eyedrop. There was no evident change in the atropine group; the axial length was obvious prolonged in tropicamide group and control group.(3) The phengophobia symptom. In the initial stages the two treatment groups had difference symptom; after 2 month later the symptom was mostly dismissed.
结果：①近视眼患病率：两治疗组的患病率均小于对照组，同时阿托品组的患病率较托品酰胺组更少；②用药前后眼轴的变化：阿托品组没有明显的变化，托品酰胺组和对照组均有显著的延长；③畏光症状：用药初期两治疗组均有不同程度的症状，用药2月后症状基本消失。
-
Methods Forty-eight rats were divided into six groups:control group, EA group, atropine group, atropine＋EA group, L-NAME group and L-NAME＋EA group. LESP was observed and recorded by using three-channel perfusion manometric measurement system.
将48只Wistar大鼠随机分成对照组、电针组、阿托品组、阿托品＋电针组、L-NAME组和L-NAME＋电针组，应用三通道微细注水式测压管和荷兰UPS-2020型食管测压系统测定大鼠LESP。
-
Objective To investigate the incidence of respiratory muscle paralysis induced by atropine overdosage during the treatment of the pesticide poisoning and explore the relationship between atropine overdosage and RMP,analyse the cause of the poisoning.
目的 研究不同农药中毒治疗中因阿托品中毒所致的呼吸肌麻痹发生率，探讨阿托品治疗与RMP的关系，并对阿托品中毒的原因进行分析。
-
The result indicated that only a partial separation of atropine racemate could be obtained with ADMPC-CSP, whereas a baseline separation of atropine racemate could be achieved with CDMPC-CSP.
在正己烷中加入了不同的醇类改性剂对阿托品进行拆分，并优化了流动相中醇类改性剂的比例。结果发现，阿托品在CDMPC固定相上可以得到基线拆分，而在ADMPC固定相上只能得到部分拆分。
-
Methods In oder to achieve atropinization rapidly and continously,moderate high-dose atropin can be used in the process of treating acute organophosporous poisoning.A restrospective review of 13 patients with severe acute organophosporous poisoning was undertaken to sum up the therapeutic action.
在抢救重度有机磷农药中毒过程中，应用大剂量阿托品以求迅速达到并维持阿托品化，根据在观察中用药的原则，依据体差异选择用药剂量。
-
Observe all the patients ingested dosage, treatment time after poisoning, cholinesterase activity on admission and the mortality; Observe the survived patients' duration of the recovery of CHE activity, the time interval to achieve atropinization from admission, the cumulative dosages of atropine to achieve atropinization, the cumulative dosages of atropine in the hospital and the incidence of intermediate syndrome.
观察全部病例的服用量，首诊时间，初诊时胆碱酯酶活力和死亡率，存活病例的CHE恢复时间，达阿托品化的时间，阿托品化的阿托品用量，病程中阿托品的总量及中间综合徵发生率。
-
Results: six patients with vagal reflection were cured by intravenous atropine, 2 with pericardial hemorrhage were treated by pericardiocentesis, 1 patient developed hypotension due to occlusion of the mitral valve orifice by the catheter was corrected by shortening the duration of the catheter in left ventricle, the blood pressure of 1 patient with rapid atrial flutter was elevated by intravenous cedilanid, the blood pressure of 1 patient with hypotension of unknown origin was elevated by vasopressor and atropine.
结果：其中迷走神经反射6例，经静脉注射阿托品纠正；心包出血2例，心包穿刺抽液血压至正常；球囊导管阻塞二尖瓣口1例，缩短导管停留在左心室时间，可以避免低血压反应；快速心房颤动1例，使用西地兰减慢心室率，血压回升；原因不明1例，经使用升压药及阿托品后血压改善。
- 更多网络解释与阿托品相关的网络解释 [注：此内容来源于网络，仅供参考]
-
atropine：阿托品[抗胆碱药]
Atromepine 阿托美品[抗胆碱药] | Atropine 阿托品[抗胆碱药] | Atropine Methonitrate 甲硝阿托品[抗胆碱药]
-
atropine sulphate：硫酸阿托品
常见於病患接受抗癌妥(Irinotecan)化疗药物时可能会出现急性胆碱性症候群,预防此副作用发生的处理方法是可以在化疗前给予硫酸阿托品(Atropine sulphate) 0.25毫克皮下注射或在症状出现后再追加硫酸阿托品(Atropine sulphate) 0.25毫克皮
-
atropine oxide：氧阿托品[抗胆碱药]
Atropine Methonitrate 甲硝阿托品[抗胆碱药] | Atropine Oxide 氧阿托品[抗胆碱药] | Auranofin 金诺芬[抗关节炎药]
-
atropine methonitrate：甲硝阿托品
atropine methobromide 溴化甲基阿托品 | atropine methonitrate 甲硝阿托品 | atropine oxide 氧阿托品
-
atropine methonitrate：甲硝阿托品[抗胆碱药]
Atropine 阿托品[抗胆碱药] | Atropine Methonitrate 甲硝阿托品[抗胆碱药] | Atropine Oxide 氧阿托品[抗胆碱药]
-
Atropine Methobromide：溴甲阿托品
将阿托品、东莨菪碱制成季氨盐例如:溴甲阿托品(Atropine Methobromide)、丁溴东莨菪碱(Scopolamine Butylbromide)解痉作用增强,中枢副作用降低. 对阿托品结构改造发展了全合成解痉药,结构类型包括:取代乙酸氨基醇酯类,氨基酰胺类,和氨基醇类,
-
Atropine Methobromide：甲溴阿托品
解痉挛作用强、中枢副作用低的M乙酰胆碱受体拮抗剂为 A、阿托品(Atropine) B、(-)-东莨菪碱((-)-Scopo-lamine) C、山莨菪碱(Anisodamine) D、樟柳碱(Anisodine) E、甲溴阿托品(Atropine Methobromide)对M1受体拮抗剂选择性较强的M乙酰胆碱受体拮抗
-
apoatropine：阿朴阿托品/阿托胺/去水阿托品
apoatropin /阿朴阿托品/ | apoatropine /阿朴阿托品/阿托胺/去水阿托品/ | apobasalt /脱玻玄武岩/
-
atropinism：阿托品中毒
atropinesulphateinjection硫酸阿托品注射液 | atropinism阿托品中毒 | atropinization阿托品处理法 阿托品化
-
atropinization：阿托品处理法 阿托品化
atropinism阿托品中毒 | atropinization阿托品处理法 阿托品化 | atropinum阿托品